JESSICA BADGER: Open Payments
NPI 1740855444 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 35 payments from 16 companies in 2025. Trend: 2023 $413 · 2024 $1,699 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $119 |
| Amgen Inc. | 5 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| AngioDynamics, Inc. | 1 | $49 |
| SCPHARMACEUTICALS INC. | 1 | $39 |
| Tactile Systems Technology Inc | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Boston Scientific Corporation | 1 | $34 |
Products named: Kerendia, VERQUVO, Repatha, JARDIANCE, LEQVIO, VENACURE 1470 PRO, FUROSCIX, Flexitouch Plus.
Industry payments across DE — which companies pay providers there.
